TherapeuticsMD (TXMD) Misses Q2 EPS by 17c

TherapeuticsMD (NASDAQ: TXMD) reported Q2 EPS of ($0.24), $0.17 worse than the analyst estimate of ($0.07).

For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.

You May Also Be Interested In

• Piper Sandler sees Google TPU sales hitting $104BN by 2028
• Top software application stocks to watch, according to Oppenheimer
• BRC Group to acquire Sangoma Technologies for ~$204M